复合式小梁切除术联合睫状体冷凝治疗晚期新生血管性青光眼

目的探讨复合式小梁切除术联合睫状体冷凝治疗晚期新生血管性青光眼的疗效。方法晚期新生血管性青光眼16例（16眼）．一次性施行180°睫状体冷凝联合复合式小梁切除术．观察术后眼压、新生血管消退情况及手术并发症。结果术后随访6—48个月，视力均无明显改善，平均眼压自（57．48±10．00）mmHg降至（12．46±4．36）mmHg，控制在21mmHg以下者13眼（占80．12％），手术眼压控制较好。结论一次性施行复合式小梁切除术联合睫状体冷凝对晚期新生血管性青光眼有较好的长期疗效。

Compound trabeculectomy and cyclocrotherapy for advanced neovascular glaucoma

Objective To explore the efficacy of compound trabeculectomy combined with cyclocrotherapy in the treatment of advanced neovascular glaucoma （NVG）. Methods Sixteen patients （16 eyes） with advanced NVG were treated with 180° peripheral retinal cyclocrotberapy and compound trabeculectomy. Postoperative intraocular pressure, iris neovascularization, and complications of the surgery were studied. Results Follow-up visits during the period of 6 to 48 months after the treatment showed that visual acuity did not manifest improvement but mean intraoeular pressure （IOP） dropped from 57.48 mmHg to 12.46 mmHg. Intraocular pressure was below 21 mmHg in 13 eyes （80.12%）. Conclusion Compound trabeculeetomy combined with cyclocrotherapy has better long-term therapeutic efficacy in treating advanced NVG.